Improving the provision and uptake of smoking cessation treatment in primary care in the United Kingdom
Lead Research Organisation:
King's College London
Department Name: Ctr for Global Health
Abstract
Smoking is a major risk factor for cancer, COPD, stroke and heart disease. The UK has a comprehensive tobacco control strategy and adult smoking prevalence has reduced considerably over the past decades, from 45% in 1974 to 14.1% in 2019. However, smoking remains one of the leading preventable causes of illness and premature death in the UK and worldwide. There is a "smoke-free 2030" ambition which aims for the smoking prevalence in England to be (less or equal to) 5% by the year 2030. However, the recent 2021 Royal College of Physicians report emphasised that current policies will not achieve the smoke-free target until after 2050. One of the challenges is inequalities, as smoking prevalence is considerably higher in disadvantaged groups.
The overarching aim of my PhD is to investigate how smoking cessation treatment is delivered in primary care in the UK and how this could be improved to further reduce the prevalence of smoking and meet the smoke-free 2030 target, including reducing the prevalence of smoking in disadvantaged groups.
This will be achieved by:
1. systematically reviewing the literature to identify what strategies to increase the provision and uptake of smoking cessation treatment in primary care have been implemented in a 'real world' setting internationally and which of these have been effective,
2. investigating (with interrupted time series analysis) the effect of policy changes on the rate of prescription of varenicline to smokers with mental health conditions,
3. exploring if and how e-cigarettes have been discussed and recorded in consultations between smokers and GPs,
4. qualitatively investigating the barriers and facilitators for GPs to prescribe e-cigarettes and smoking cessation treatments, particularly varenicline.
The overarching aim of my PhD is to investigate how smoking cessation treatment is delivered in primary care in the UK and how this could be improved to further reduce the prevalence of smoking and meet the smoke-free 2030 target, including reducing the prevalence of smoking in disadvantaged groups.
This will be achieved by:
1. systematically reviewing the literature to identify what strategies to increase the provision and uptake of smoking cessation treatment in primary care have been implemented in a 'real world' setting internationally and which of these have been effective,
2. investigating (with interrupted time series analysis) the effect of policy changes on the rate of prescription of varenicline to smokers with mental health conditions,
3. exploring if and how e-cigarettes have been discussed and recorded in consultations between smokers and GPs,
4. qualitatively investigating the barriers and facilitators for GPs to prescribe e-cigarettes and smoking cessation treatments, particularly varenicline.
Organisations
People |
ORCID iD |
Leonie Brose (Primary Supervisor) | |
Bernadett Erika Tildy (Student) |
Publications
Perman-Howe P
(2022)
The Effect of Tobacco Control Mass Media Campaigns on Smoking-Related Behavior Among People With Mental Illness: A Systematic Literature Review
in Nicotine & Tobacco Research
Tildy BE
(2023)
Implementation strategies to increase smoking cessation treatment provision in primary care: a systematic review of observational studies.
in BMC primary care
Studentship Projects
Project Reference | Relationship | Related To | Start | End | Student Name |
---|---|---|---|---|---|
ES/P000703/1 | 30/09/2017 | 29/09/2027 | |||
2314529 | Studentship | ES/P000703/1 | 30/09/2019 | 30/03/2024 | Bernadett Erika Tildy |
Description | Travel Grant |
Amount | £940 (GBP) |
Organisation | Guarantors of Brain |
Sector | Charity/Non Profit |
Country | United Kingdom |
Start | 09/2022 |
End | 12/2022 |
Description | Webinar for National Drug & Alcohol Research Centre (NDARC) in Australia |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | I was invited as a guest speaker as part of the National Drug and Alcohol Research Centre (NDARC) webinar series on Thu 24th Nov 2022. The webinar series attracts an audience of 100-150 attendees on the day, with a similar number viewing over the next month. The audience is broad, comprising clinicians, treatment workers, people working in policy and researchers; the general interest is in the clinical and public health implications of research. I gave a 35-minute presentation, providing a background to the UK smoking and vaping context and my PhD studies then participated in a Q&A. The webinar was chaired by Prof Shane Darke and they invited Prof Hayden McRobbie on as a panel member for the Q&A part of the webinar. 89 people attended on the day. https://ndarc.med.unsw.edu.au/resource/reaching-smoke-free-how-can-we-improve-smoking-cessation-treatment |
Year(s) Of Engagement Activity | 2022 |
URL | https://ndarc.med.unsw.edu.au/resource/reaching-smoke-free-how-can-we-improve-smoking-cessation-trea... |